Cefuroxime Axetil | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Cefuroxime Axetil
USP

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Cefuroxime Axetil

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 39 USDMF, 21 CEP/COS, 11 EU WC, 22 KDMF, 4 NDC API, 15 Listed Suppliers, $ API Reference Price

58 API Suppliers
39 USDMF
21 CEP/COS
11 EU WC
22 KDMF
4 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

221 FDF Dossiers, 34 FDA Orange Book, 112 Europe, 5 Canada, 8 South Africa, 62 Listed Dossiers

221 FDF Dossiers
34 FDA Orange Book
112 Europe
5 Canada
8 South Africa
62 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML, FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML

TABLET;ORAL - EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML
FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML

RELATED EXCIPIENT COMPANIES

1 Evonik, 4 Rochem International Inc, 19 SPI Pharma, 2 Seqens, 7 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 19 BASF, 2 Clariant, 12 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 37 Direct Compression, 32 Controlled & Modified Release, 29 Thickeners and Stabilizers, 28 Lubricants & Glidants, 22 Taste Masking, 21 Solubilizers, 20 Topical, 19 Disintegrants & Superdisintegrants, 19 Granulation, 19 Co-Processed Excipients, 18 Chewable & Orodispersible Aids, 18 Parenteral, 16 Film Formers & Plasticizers, 11 Emulsifying Agents, 8 API Stability Enhancers, 7 Rheology Modifiers, 5 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents

65 Fillers, Diluents & Binders
56 Coating Systems & Additives
37 Direct Compression
32 Controlled & Modified Release
29 Thickeners and Stabilizers
28 Lubricants & Glidants
22 Taste Masking
21 Solubilizers
20 Topical
19 Disintegrants & Superdisintegrants
19 Granulation
19 Co-Processed Excipients
18 Chewable & Orodispersible Aids
18 Parenteral
16 Film Formers & Plasticizers
11 Emulsifying Agents
8 API Stability Enhancers
7 Rheology Modifiers
5 Surfactant & Foaming Agents
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 11 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
11 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 112 Finished Drug Prices

1 US Medicaid Prescriptions
112 Finished Drug Prices

MARKET PLACE

25 APIs, 30 FDF Dossiers

25 APIs
30 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 Health Canada Patents

9 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 3 USP, 5 Others

1 EDQM
3 USP
5 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 137 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

3 All

01 11098220

02 11098231

03 11098253

filter Description Reset all filters

3 All

01 1Cefuroxime Axetil (350 mg)

02 1Cefuroxime Axetil Delta-3-Isomers (10 mg) ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate)

03 1Cefuroxime Axetil E-isomers (15 mg) (1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate)

filter CAS Number Reset all filters

3 All

01 164544-07-6

02 197232-96-7

03 1N/A

Product Main Page

01

USP

Fi Europe 2024

Not Confirmed

USP

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cefuroxime Axetil E-isomers (15 mg) (1RS,6R,7...

CAS Number : 97232-96-7

Quantity Per Vial :

Price ($) : 715

Catalog Number : 1098253

Current Lot : F034U0

Previous Lot :

NDC Code :

Product Web Link

Digital Content

02

USP

Fi Europe 2024

Not Confirmed

USP

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cefuroxime Axetil Delta-3-Isomers (10 mg) ((1...

CAS Number : N/A

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1098231

Current Lot : R04630

Previous Lot : J0K016 (30-SEP-2017)

NDC Code :

Product Web Link

Digital Content

03

USP

Fi Europe 2024

Not Confirmed

USP

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cefuroxime Axetil (350 mg)

CAS Number : 64544-07-6

Quantity Per Vial :

Price ($) : 230

Catalog Number : 1098220

Current Lot : R011M0

Previous Lot : H0K039 (30-SEP-2015)

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?